Trials / Unknown
UnknownNCT04124913
Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles
Comparison of Oral Dydrogesterone Versus Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles: a Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Memorial Sisli Hospital, Istanbul · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The aim of this randomized controlled trial is to compare the efficacy of oral dydrogesterone vs. micronized vaginal progesterone for luteal phase support in frozen-thawed embryo transfer cycles.
Conditions
- Infertility, Female
- Infertility, Male
- Embryo Transfer
- Fertilization in Vitro
- Drug Effect
- Reproductive Techniques, Assisted
- Progesterone
- Dydrogesterone
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dydrogesterone 10 MG Oral Tablet | Oral dydrogesterone 10 mg tablet three times a day for luteal phase support |
| DRUG | Progesterone Vaginal Gel [Crinone] | Vaginal progesterone gel 90 mg once a day for luteal phase support |
Timeline
- Start date
- 2019-01-02
- Primary completion
- 2019-10-01
- Completion
- 2019-12-01
- First posted
- 2019-10-14
- Last updated
- 2019-10-14
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04124913. Inclusion in this directory is not an endorsement.